ID SPA12_HUMAN Reviewed; 414 AA. AC Q8IW75; DT 27-SEP-2005, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 16-JUN-2009, entry version 51. DE RecName: Full=Serpin A12; DE AltName: Full=Visceral adipose tissue-derived serine protease inhibitor; DE Short=Vaspin; DE AltName: Full=Visceral adipose-specific serpin; DE AltName: Full=OL-64; DE Flags: Precursor; GN Name=SERPINA12; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=16030142; DOI=10.1073/pnas.0504703102; RA Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., RA Hashimoto I., Okada T., Yasuhara A., Nakatsuka A., Shikata K., RA Hourai S., Futami J., Watanabe E., Matsuki Y., Hiramatsu R., Akagi S., RA Makino H., Kanwar Y.S.; RT "Visceral adipose tissue-derived serine protease inhibitor: a unique RT insulin-sensitizing adipocytokine in obesity."; RL Proc. Natl. Acad. Sci. U.S.A. 102:10610-10615(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Heart; RA Chen S., Guo J.H., Yu L.; RL Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: May modulates insulin action conceivably only in the CC presence of its yet undefined target proteases in white adipose CC tissues. CC -!- SUBCELLULAR LOCATION: Secreted (Potential). CC -!- TISSUE SPECIFICITY: Expressed in visceral adipose tissues. CC -!- SIMILARITY: Belongs to the serpin family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AY326420; AAP88384.1; -; mRNA. DR EMBL; AY177692; AAO18649.1; -; mRNA. DR EMBL; BC040857; AAH40857.1; -; mRNA. DR IPI; IPI00219476; -. DR RefSeq; NP_776249.1; -. DR UniGene; Hs.99476; -. DR HSSP; P01009; 1QMB. DR MEROPS; I04.965; -. DR PRIDE; Q8IW75; -. DR Ensembl; ENSG00000165953; Homo sapiens. DR GeneID; 145264; -. DR KEGG; hsa:145264; -. DR GeneCards; GC14M094023; -. DR H-InvDB; HIX0026658; -. DR HGNC; HGNC:18359; SERPINA12. DR PharmGKB; PA134863157; -. DR HOGENOM; Q8IW75; -. DR HOVERGEN; Q8IW75; -. DR OMA; Q8IW75; AQTLPME. DR NextBio; 85065; -. DR ArrayExpress; Q8IW75; -. DR Bgee; Q8IW75; -. DR CleanEx; HS_SERPINA12; -. DR GermOnline; ENSG00000165953; Homo sapiens. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW. DR InterPro; IPR000215; Protease_inhib_I4_serpin. DR PANTHER; PTHR11461; Prot_inh_serpin; 1. DR Pfam; PF00079; Serpin; 1. DR SMART; SM00093; SERPIN; 1. DR PROSITE; PS00284; SERPIN; FALSE_NEG. PE 2: Evidence at transcript level; KW Glycoprotein; Polymorphism; Protease inhibitor; Secreted; KW Serine protease inhibitor; Signal. FT SIGNAL 1 20 By similarity. FT CHAIN 21 414 Serpin A12. FT /FTId=PRO_0000041976. FT CARBOHYD 221 221 N-linked (GlcNAc...) (Potential). FT CARBOHYD 233 233 N-linked (GlcNAc...) (Potential). FT CARBOHYD 267 267 N-linked (GlcNAc...) (Potential). FT VARIANT 142 142 Q -> K (in dbSNP:rs17090972). FT /FTId=VAR_051943. FT VARIANT 394 394 I -> V (in dbSNP:rs34519784). FT /FTId=VAR_051944. SQ SEQUENCE 414 AA; 47175 MW; 5C70F1AB5935661C CRC64; MNPTLGLAIF LAVLLTVKGL LKPSFSPRNY KALSEVQGWK QRMAAKELAR QNMDLGFKLL KKLAFYNPGR NIFLSPLSIS TAFSMLCLGA QDSTLDEIKQ GFNFRKMPEK DLHEGFHYII HELTQKTQDL KLSIGNTLFI DQRLQPQRKF LEDAKNFYSA ETILTNFQNL EMAQKQINDF ISQKTHGKIN NLIENIDPGT VMLLANYIFF RARWKHEFDP NVTKEEDFFL EKNSSVKVPM MFRSGIYQVG YDDKLSCTIL EIPYQKNITA IFILPDEGKL KHLEKGLQVD TFSRWKTLLS RRVVDVSVPR LHMTGTFDLK KTLSYIGVSK IFEEHGDLTK IAPHRSLKVG EAVHKAELKM DERGTEGAAG TGAQTLPMET PLVVKIDKPY LLLIYSEKIP SVLFLGKIVN PIGK //